Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.
Gain Therapeutics, Inc.’s GANX share price has surged by 10.41%, which has investors questioning if this is right time to sell.
Innovative designs of GPCRs with enhanced signaling and stability offer new insights for drug discovery and synthetic biology ...
University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...
Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...
More information: Pankaj Pandey et al, Determination of the Negative Allosteric Binding Site of Cannabidiol at the CB1 Receptor: A Combined Computational and Site-Directed Mutagenesis Study ...
Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...
Cancer Molecular Therapeutics Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 N Torrey Pines Rd, La Jolla, California 92037, United States ...
This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback